ADYNOVI

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug ADYNOVI contains one active pharmaceutical ingredient (API):

1
UNII 5X3GF74R79 - ANTIHEMOPHILIC FACTOR, PEGYLATED (MW 20000) HUMAN SEQUENCE RECOMBINANT
 

Rurioctocog alfa pegol, is a pegylated recombinant human factor VIII with an extended half-life. Rurioctocog alfa pegol is a covalent conjugate of octocog alfa consisting of 2,332 amino acids with polyethylene glycol (PEG) reagent (MW 20 kDa). The therapeutic activity of rurioctocog alfa pegol is derived from octocog alfa, which is produced by recombinant DNA technology from a Chinese hamster ovary cell line. Octocog alfa is then covalently conjugated with the PEG reagent. The PEG moiety is conjugated to octocog alfa to increase the plasma half-life.

 
Read more about Rurioctocog alfa pegol

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ADYNOVI Powder and solvent for solution for injection MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B02BD02 Coagulation factor VIII B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1762444, 1762455, 1762466, 1762477, 1762488, 1762499, 1762501, 1873111
ES Centro de información online de medicamentos de la AEMPS 1171247002, 1171247006, 1171247010, 1171247014
FI Lääkealan turvallisuus- ja kehittämiskeskus 144598, 189503, 524776
FR Base de données publique des médicaments 61598943
GB Medicines & Healthcare Products Regulatory Agency 387007, 387010, 387015, 387018
LT Valstybinė vaistų kontrolės tarnyba 1084806, 1084807, 1084808, 1084809, 1084810, 1084811, 1084812, 1084813, 1084814, 1084815, 1084816, 1084817, 1084818, 1084819
NL Z-Index G-Standaard 14934590
NL Z-Index G-Standaard, PRK 149292, 149306, 149314, 167940
PL Rejestru Produktów Leczniczych 100400720, 100400908, 100400914, 100400920, 100465053
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W66273001, W66273002, W66274001, W66274002, W66275001, W66275002, W66276001, W66276002, W66507001, W66508001, W66509001, W68368001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.